Advanced search
Publication Cover
Journal of Psychoactive Drugs Volume 34, 2002 - Issue 2: The State of Ecstasy: MDMA - Science and Policy
Submit an article Journal homepage
446
Views
67
CrossRef citations to date
0
Altmetric
The State of Ecstasy: MDMA—Science and Policy

MDMA: A Review of Epidemiological Data

Mim J. Landry Danya International, Inc., Silver Spring, Maryland
Pages 163-169 | Published online: 06 Sep 2011

Citations (67)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (10)

Siddharth Chandra, Yan-Liang Yu & Vinay Bihani. (2017) How MDMA flows across the USA: evidence from price data. Global Crime 18:2, pages 122-139.
Read now
Zhao Helen Wu, James J. Grady, Stephen Rosales & Abbey B. Berenson. (2011) Ecstasy Use and Its Correlates Among Young, Low-Income Women. Substance Use & Misuse 46:4, pages 404-410.
Read now
Patrick McCrystal & Andrew Percy. (2010) Factors associated with teenage ecstasy use. Drugs: Education, Prevention and Policy 17:5, pages 507-527.
Read now
Rif S. El-Mallakh & Henry David Abraham. (2007) MDMA (Ecstasy). Annals of Clinical Psychiatry 19:1, pages 45-52.
Read now
StevenL. West & CarolynW. Graham. (2005) A Survey of Substance Abuse Prevention Efforts at Virginia's Colleges and Universities. Journal of American College Health 54:3, pages 185-191.
Read now
MichaelG. Vaughn, MatthewO. Howard & MaryP. Curtis. (2005) Is Ecstasy (MDMA) Use Associated with Symptoms of Anxiety or Depression Among Incarcerated Juvenile Offenders?. Journal of Evidence-Based Social Work 2:3-4, pages 19-34.
Read now
Christopher P. Krebs & Danielle M. Steffey. (2005) Club Drug Use Among Delinquent Youth. Substance Use & Misuse 40:9-10, pages 1363-1379.
Read now
Jill A. McCaughan, Robert G. Carlson, Russel S. Falck & Harvey A. Siegal. (2005) From “Candy Kids” to “Chemi-Kids”: A Typology of Young Adults Who Attend Raves in the Midwestern United States. Substance Use & Misuse 40:9-10, pages 1503-1523.
Read now
Caleb Banta-Green, Gary Goldbaum, Susan Kingston, Matthew Golden, Richard Harruff & Barry K. Logan. (2005) Epidemiology of MDMA and Associated Club Drugs in the Seattle Area. Substance Use & Misuse 40:9-10, pages 1295-1315.
Read now
RobertG. Carlson, RusselS. Falck, JillA. McCaughan & HarveyA. Siegal. (2004) MDMA/Ecstasy Use Among Young People in Ohio: Perceived Risk and Barriers to Intervention. Journal of Psychoactive Drugs 36:2, pages 181-189.
Read now

Articles from other publishers (57)

Arash Ghaffari-Rafi, Ki Suk Eum, Jesus Villanueva & Jay Jahanmir. (2020) Protracted hyperthermia and delayed rhabdomyolysis in ecstasy toxicity. Medicine 99:41, pages e21842.
Crossref
MARCELA C. SMID, TORRI D. METZ & ADAM J. GORDON. (2019) Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women. Clinical Obstetrics & Gynecology 62:1, pages 168-184.
Crossref
Felix Betzler, Leonard Viohl & Nina Romanczuk‐Seiferth. (2016) Decision‐making in chronic ecstasy users: a systematic review. European Journal of Neuroscience 45:1, pages 34-44.
Crossref
Maggie L. McNulty, Andreas Luft & Thomas P. Bleck. 2017. Seizures in Critical Care. Seizures in Critical Care 343 353 .
Andrew C. McCreary, Christian P. Müller & Małgorzata Filip. 2015. The Neuropsychiatric Complications of Stimulant Abuse. The Neuropsychiatric Complications of Stimulant Abuse 41 83 .
Suely K. S. S. Porto, Thiago Nogueira, Lucas Blanes, Philip Doble, Bruno D. Sabino, Claudimir L. do Lago & Lúcio Angnes. (2014) Analysis of Ecstasy Tablets Using Capillary Electrophoresis with Capacitively Coupled Contactless Conductivity Detection . Journal of Forensic Sciences 59:6, pages 1622-1626.
Crossref
F. J. van der Meer, J. H. Meijer, C. J. Meijer, W. van den Brink & E. Velthorst. (2013) Cognitive functioning associated with stimulant use in patients with non-affective psychosis, their unaffected siblings and healthy controls. Psychological Medicine 44:9, pages 1901-1911.
Crossref
Firas Kobeissy, Tarek H. Mouhieddine, Amaly Nokkari, Muhieddine Itani, Mohammed Mouhieddine, Zhiqun Zhang, Rui Zhu, Mark S. Gold, Kevin K. Wang & Yehia Mechref. (2014) Recent updates on drug abuse analyzed by neuroproteomics studies: Cocaine, Methamphetamine and MDMA. Translational Proteomics 3, pages 38-52.
Crossref
Luo Zhuo, Quan Liu, Liang Liu, Ting-yi Sun, Rong-shuai Wang, Guo-qiang Qu, Qian Liu, Yan Liu & Liang Ren. (2013) Roles of 3,4-methylenedioxymethamphetamine (MDMA)-induced alteration of connexin43 and intracellular Ca2+ oscillation in its cardiotoxicity. Toxicology 310, pages 61-72.
Crossref
Donald G. BarcelouxNicholas A. Buckley. 2012. Medical Toxicology of Drug Abuse. Medical Toxicology of Drug Abuse 126 155 .
Donald G. BarcelouxBrandon Wills & Timothy Erickson. 2012. Medical Toxicology of Drug Abuse. Medical Toxicology of Drug Abuse 156 192 .
Ujjwal P. Ramtekkar, Catherine W. Striley & Linda B. Cottler. (2011) Contextual profiles of young adult ecstasy users: A multisite study. Addictive Behaviors 36:3, pages 190-196.
Crossref
Vijay V. Upreti, Kwan‐Hoon Moon, Li‐Rong Yu, Insong J. Lee, Natalie D. Eddington, Xiaoying Ye, Timothy D. Veenstra & Byoung‐Joon Song. (2010) Increased oxidative‐modifications of cytosolic proteins in 3,4‐methylenedioxymethamphetamine (MDMA, ecstasy)‐exposed rat liver. PROTEOMICS 11:2, pages 202-211.
Crossref
Ana B Fagundo, Elisabet Cuyàs, Antonio Verdejo-Garcia, Olha Khymenets, Klaus Langohr, Rocio Martín-Santos, Magí Farré & Rafael de la Torre. (2010) The influence of 5-HTT and COMT genotypes on verbal fluency in ecstasy users. Journal of Psychopharmacology 24:9, pages 1381-1393.
Crossref
Kenneth J. Broadley. (2010) The vascular effects of trace amines and amphetamines. Pharmacology & Therapeutics 125:3, pages 363-375.
Crossref
Vibeke S. Catts & Stanley V. Catts. 2011. Secondary Schizophrenia. Secondary Schizophrenia 141 168 .
Andreas R. Luft. 2010. Seizures in Critical Care. Seizures in Critical Care 341 354 .
Gjalt-Jorn Ygram Peters & Gerjo Kok. (2009) A structured review of reasons for ecstasy use and related behaviours: pointers for future research. BMC Public Health 9:1.
Crossref
Michael H. Baumann & Richard B. Rothman. 2009. New Concepts of Psychostimulant Induced Neurotoxicity. New Concepts of Psychostimulant Induced Neurotoxicity 257 296 .
Frank Eifinger, Bernhard Roth, Lars Kröner & Markus A. Rothschild. (2007) Severe Ecstasy poisoning in an 8-month-old infant. European Journal of Pediatrics 167:9, pages 1067-1070.
Crossref
Kwan‐Hoon Moon, Vijay V. Upreti, Li‐Rong Yu, Insong J. Lee, Xiaoying Ye, Natalie D. Eddington, Timothy D. Veenstra & Byoung‐Joon Song. (2008) Mechanism of 3,4‐methylenedioxymethamphetamine (MDMA, ecstasy)‐mediated mitochondrial dysfunction in rat liver. PROTEOMICS 8:18, pages 3906-3918.
Crossref
Daniel A. Nelson, Jamie L. Nirmaier, Sam J. Singh, Melanie D. Tolbert & Kenneth L. Bost. (2008) Ecstasy (3,4-methylenedioxymethamphetamine) limits murine gammaherpesvirus-68 induced monokine expression. Brain, Behavior, and Immunity 22:6, pages 912-922.
Crossref
Vijay V. Upreti & Natalie D. Eddington. (2008) Fluoxetine Pretreatment Effects Pharmacokinetics of 3,4‐Methylenedioxymethamphetamine (MDMA, ECSTASY) in Rat. Journal of Pharmaceutical Sciences 97:4, pages 1593-1605.
Crossref
John A. Tilelli. 2008. Pediatric Emergency Medicine. Pediatric Emergency Medicine 950 969 .
Daniel A. Nelson, Melanie D. Tolbert, Sam J. Singh & Kenneth L. Bost. (2007) Expression of Neuronal Trace Amine-associated Receptor (Taar) mRNAs in Leukocytes. Journal of Neuroimmunology 192:1-2, pages 21-30.
Crossref
Michael Baumann & Richard Rothman. 2007. Neurochemistry of Abused Drugs. Neurochemistry of Abused Drugs 119 142 .
Giada Frenzilli, Michela Ferrucci, Filippo Sean Giorgi, Fabio Blandini, Marco Nigro, Stefano Ruggieri, Luigi Murri, Antonio Paparelli & Francesco Fornai. (2007) DNA fragmentation and oxidative stress in the hippocampal formation: a bridge between 3,4-methylenedioxymethamphetamine (ecstasy) intake and long-lasting behavioral alterations. Behavioural Pharmacology 18:5-6, pages 471-481.
Crossref
Kathryn E. Baker, Amy A. Herbert & Kenneth J. Broadley. (2007) Vasoconstriction of porcine left anterior descending coronary artery by ecstasy and cathinone is not an indirect sympathomimetic effect. Vascular Pharmacology 47:1, pages 10-17.
Crossref
Brian J. Piper. (2007) A developmental comparison of the neurobehavioral effects of ecstasy (MDMA). Neurotoxicology and Teratology 29:2, pages 288-300.
Crossref
Kelly Allott & Jennifer Redman. (2007) Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?. Neuroscience & Biobehavioral Reviews 31:3, pages 327-347.
Crossref
A. Villa, F. Baud, B. Megarbane, F. Lapostolle, R. Garnier & C. Bismuth. (2007) Intoxications aiguës les plus fréquentes. EMC - Médecine d 'urgence 2:1, pages 1-31.
Crossref
A. Villa, F. Baud, B. Megarbane, F. Lapostolle, R. Garnier & C. Bismuth. (2007) Avvelenamenti acuti più frequenti. EMC - Urgenze 11:4, pages 1-30.
Crossref
Michael H. Baumann, Xiaoying Wang & Richard B. Rothman. (2006) 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology 189:4, pages 407-424.
Crossref
Julie Staley & Kelly Cosgrove. 2006. Drug Abuse Handbook, Second Edition. Drug Abuse Handbook, Second Edition 429 558 .
Gunjan M Modi, Pamela B Yang, Alan C Swann & Nachum Dafny. (2006) Chronic exposure to MDMA (Ecstasy) elicits behavioral sensitization in rats but fails to induce cross-sensitization to other psychostimulants. Behavioral and Brain Functions 2:1.
Crossref
Boris B. Quednow, Kai-Uwe Kühn, Christian Hoppe, Jens Westheide, Wolfgang Maier, Irene Daum & Michael Wagner. (2006) Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA (“Ecstasy”). Psychopharmacology 189:4, pages 517-530.
Crossref
Li-Tzy Wu, William E. Schlenger & Deborah M. Galvin. (2006) Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths. Drug and Alcohol Dependence 84:1, pages 102-113.
Crossref
JERROLD S. MEYER, MATTHEW E. BREVARD, BRIAN J. PIPER, SYED F. ALI & CRAIG F. FERRIS. (2006) Neural Effects of MDMA as Determined by Functional Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Awake Marmoset Monkeys. Annals of the New York Academy of Sciences 1074:1, pages 365-376.
Crossref
FILIPPO S. GIORGI, GLORIA LAZZERI, GIANFRANCO NATALE, ALFONSO IUDICE, STEFANO RUGGIERI, ANTONIO PAPARELLI, LUIGI MURRI & FRANCESCO FORNAI. (2006) MDMA and Seizures: A Dangerous Liaison?. Annals of the New York Academy of Sciences 1074:1, pages 357-364.
Crossref
Emily E. Tanner-Smith. (2006) Pharmacological content of tablets sold as “ecstasy”: Results from an online testing service. Drug and Alcohol Dependence 83:3, pages 247-254.
Crossref
Boris B. Quednow, Frank Jessen, Kai-Uwe Kühn, Wolfgang Maier, Irene Daum & Michael Wagner. (2005) Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction. Journal of Psychopharmacology 20:3, pages 373-384.
Crossref
Fabrizio Schifano, John Corkery, Paolo Deluca, Adenekan Oyefeso & A. Hamid Ghodse. (2005) Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994–2003). Journal of Psychopharmacology 20:3, pages 456-463.
Crossref
Zhao Helen Wu, Charles E. HolzerIIIIII, Carmen Radecki Breitkopf, James J. Grady & Abbey B. Berenson. (2006) Patterns and perceptions of ecstasy use among young, low-income women. Addictive Behaviors 31:4, pages 676-685.
Crossref
Cynthia A. Crawford, Michael T. Williams, Jodie L. Kohutek, Fiona Y. Choi, Shelly T. Yoshida, Sanders A. McDougall & Charles V. Vorhees. (2006) Neonatal 3,4-methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase A activity, serotonin and dopamine content, and [35S]GTPγS binding in adult rats. Brain Research 1077:1, pages 178-186.
Crossref
Robert G. Carlson, Jichuan Wang, Russel S. Falck & Harvey A. Siegal. (2005) Drug use practices among MDMA/ecstasy users in Ohio: a latent class analysis. Drug and Alcohol Dependence 79:2, pages 167-179.
Crossref
William L. JacksonJrJr. (2005) Toward directed therapy for amphetamine-mediated hyperthermia: Is carvedilol worth raving about?*. Critical Care Medicine 33:6, pages 1443-1445.
Crossref
Michael H Baumann, Robert D Clark, Allison G Budzynski, John S Partilla, Bruce E Blough & Richard B Rothman. (2004) N-Substituted Piperazines Abused by Humans Mimic the Molecular Mechanism of 3,4-Methylenedioxymethamphetamine (MDMA, or ‘Ecstasy’). Neuropsychopharmacology 30:3, pages 550-560.
Crossref
Silvia S. Martins, Guido Mazzotti & Howard D. Chilcoat. (2005) Trends in ecstasy use in the United States from 1995 to 2001: Comparison with marijuana users and association with other drug use.. Experimental and Clinical Psychopharmacology 13:3, pages 244-252.
Crossref
F.S. Giorgi, C. Pizzanelli, M. Ferrucci, G. Lazzeri, M. Faetti, M. Giusiani, F. Pontarelli, C.L. Busceti, L. Murri & F. Fornai. (2005) Previous exposure to (±) 3,4-methylenedioxymethamphetamine produces long-lasting alteration in limbic brain excitability measured by electroencephalogram spectrum analysis, brain metabolism and seizure susceptibility. Neuroscience 136:1, pages 43-53.
Crossref
Andreas R. Luft. 2005. Seizures in Critical Care. Seizures in Critical Care 291 304 .
Kirsten C. Morley, Jennifer L. Cornish, Kong M. Li & Iain S. McGregor. (2004) Preexposure to MDMA (“Ecstasy”) delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats. Pharmacology Biochemistry and Behavior 79:2, pages 331-342.
Crossref
Pedro Rosa‐Neto, Albert Gjedde, Aage K. Olsen, Svend B. Jensen, Ole L. Munk, Hideaki Watanabe & Paul Cumming. (2004) MDMA‐evoked changes in [ 11 C]raclopride and [ 11 C]NMSP binding in living pig brain . Synapse 53:4, pages 222-233.
Crossref
Pedro Rosa‐Neto, Aage K. Olsen, Albert Gjedde, Hideaki Watanabe & Paul Cumming. (2004) MDMA‐evoked changes in cerebral blood flow in living porcine brain: Correlation with hyperthermia. Synapse 53:4, pages 214-221.
Crossref
Robert G Carlson, Jill A McCaughan, Russel S Falck, Jichuan Wang, Harvey A Siegal & Raminta Daniulaityte. (2004) Perceived adverse consequences associated with MDMA/Ecstasy use among young polydrug users in Ohio: implications for intervention. International Journal of Drug Policy 15:4, pages 265-274.
Crossref
F. L?pez-Mu?oz, G. Rubio, E. Gonz?lez-Mart?nez & C. ?lamo. (2004) ?xtasis (3,4-metilendioximetanfetamina, MDMA): aspectos farmacol?gicos, cl?nicos y criminol?gicos. Trastornos Adictivos 6:1, pages 16-38.
Crossref
Michael Fendrich, Joseph S. Wislar, Timothy P. Johnson & Amy Hubbell. (2003) A contextual profile of club drug use among adults in Chicago. Addiction 98:12, pages 1693-1703.
Crossref
Edward M. Mills, Matthew L. Banks, Jon E. Sprague & Toren Finkel. (2003) Uncoupling the agony from ecstasy. Nature 426:6965, pages 403-404.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.